Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Polyplastics Expands DURACON (R) POM PM Series with New High-flow Grade for Medical and Healthcare Industry

TOKYO, Feb. 25, 2021 /PRNewswire/ -- The Polyplastics Group is expanding its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON PM27S01N, offe...

2021-02-25 15:00 2270

Elekta appoints Johan Adebäck as Chief Financial Officer

STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He has held the position of Acting CFO sinceJune 2, 2020. Prior to the Acting CFO position, Johan Adebäck had been Group Tr...

2021-02-25 14:52 4852

Astana Club: TOP-10 Risks for Eurasia Are Already Coming True in 2021

NUR-SULTAN, Kazakhstan, Feb. 25, 2021 /PRNewswire/ -- Astana Club , one of the most esteemed geopolitical forums for Europe and Asia, announces the latest edition of the international rating "TOP-10 Risks for Eurasia in 2021" ....

2021-02-25 09:00 1910

Gannex Announces U.S. IND Approval and Initiation of Global Development of THR-β Agonist ASC41 for NASH

SHANGHAI, Feb. 24, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of nonalcoholic steatohepatitis (NASH), today announces the Investigational New Drug Application (IND) approval ...

2021-02-25 08:30 2688

WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories

SHANGHAI, Feb. 25, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that the company has been named a winner of the 2021 CMO Leadership Awards for a fourth year in a row. The company is proud to ...

2021-02-25 08:00 1730

Turnaround on track at Comvita

TAURANGA, New Zealand, Feb. 24, 2021 /PRNewswire/ -- Headlines * Reported NPAT $3.5M vs. ($13M) in PCP * Reported EBITDA* $10.6M vs. ($8.8M) in PCP, an improvement of $19.4M * Reported revenue $98.9M, +5.5% vs. PCP * Double-digit top and bottom-line growth in focus growth markets * Net ...

2021-02-25 07:38 6446

New FDI World Dental Federation global survey reveals that two-thirds of countries are not allowing dentists to administer COVID-19 vaccines

Survey also shows that half of the responding countries have agreed to include dentists in their priority vaccination groups GENEVA, Feb. 25, 2021 /PRNewswire/ -- FDI World Dental Federation today called for more countries to enable dentists to administe...

2021-02-25 07:01 2407

Genome & Company and Debiopharm Join Forces To Create New Highly Specific Therapies for Cancer Patients

SEOUL, South Korea, Feb. 24, 2021 /PRNewswire/ -- Genome & Company (314130, CEO: Jisoo Pae, Hansoo Park), a global leading immuno-oncology firm, and Debiopharm, a Swiss-based biopharmaceutical company specializing in oncology and infectious diseases, today announced having entered into a research ...

2021-02-25 07:00 1960

Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2021

HONG KONG, Feb. 25, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...

2021-02-25 05:16 9794

Game-Changing Wrinkle Reduction Device Receives Key Regulatory Clearance in Canada

Sofwave is crucial to your aesthetic practice. Learn Why! YOQNEAM, Israel, Feb. 25, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received clearance from Health Canada for its next-generat...

2021-02-25 01:00 1738

Insilico Medicine Achieves Industry First Nominating Preclinical Candidate Discovered by AI

Insilico Medicine Achieves Industry First Nominating Preclinical Candidate for Idiopathic Pulmonary Fibrosis With Both Novel Drug Target and Novel Molecule Discovered by Artificial Intelligence HONG KONG, Feb. 25, 2021 /PRNewswire/ -- Insilico Medicine has demonstrated a breakthrough in Artifici...

2021-02-25 00:48 2421

First cancer centers begin using initial release of Elekta's MOSAIQ 3 series

ATLANTA, Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that several cancer centers are the early adopters of the company's first release in the MOSAIQ® 3* series. Featuring increased automation and simplified user interfaces, MOSAIQ 3 is designed to significantly reduce workflo...

2021-02-25 00:46 4793

Zymergen Appoints Global Finance Expert Enakshi Singh as Chief Financial Officer

EMERYVILLE, Calif., Feb. 24, 2021 /PRNewswire/ -- Biofacturing leader Zymergen today announced it has promotedEnakshi (Ena) Singh to Chief Financial Officer. Singh has helped Zymergen close more than$1B in equity financing and $100M in debt since joining Zymergen as vice president of finance in 2...

2021-02-24 22:30 4538

Zymergen Appoints Global Finance Expert Enakshi Singh as Chief Financial Officer

VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV Infections

- VLP BioTech Has Developed a Vaccine-Based Viral-Entry-Inhibitor for the Treatment of Chronic HBV/HDV. - The Vaccine-Based Treatment Has Significant Advantages Compared to a Peptide-Based, Entry-Inhibitor (Hepcludex). SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- VLP BioTech, Inc., a private, pre...

2021-02-24 22:00 2721

I-Mab Announces Upcoming Participation at March Conferences

SHANGHAI and GAITHERSBURG, Md., Feb. 24, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in March....

2021-02-24 21:00 4641

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure

SCHAFFHAUSEN, Switzerland, Feb. 24, 2021 /PRNewswire/ -- Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of the novel Atrial Flow Regulator (AFR) in heart failure (HF) patients (PRELIEVE trial). PRELIEVE is...

2021-02-24 20:41 2087

MedTech to Take Advantage of Digital Health Platform as a Service Model to Accelerate Digital Transformation across the Healthcare Industry

A proven, compliant platform can expedite market entry and optimize time and effort without building competencies internally, finds Frost & Sullivan SANTA CLARA, Calif., Feb. 24, 2021 /PRNewswire/ -- MedTech and Life Sciences companies are transitioning beyondbiopharmaceuticals, medical devices, ...

2021-02-24 20:02 1710

Advanced Aesthetic Technologies, Inc.'s Algeness® Chosen as a Top Finalist in Prestigious Terra2 Solution Skin Health Innovation Competition

BROOKLINE, Mass., Feb. 24, 2021 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, is proud to announce that AAT and our lead product Algeness® were selected as one of the top two finalists in the recent Terra2 Solutions Skin Health Innovati...

2021-02-24 19:00 2433

Mohamed bin Zayed University of Artificial Intelligence and Weizmann Institute of Science establish joint AI Program

- New collaborative projects will facilitate joint research projects, training programs, conferences, student exchange programs and more ABU DHABI, UAE, Feb. 24, 2021 /PRNewswire/ -- The Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and the Weizmann Institute of Science (WIS) ...

2021-02-24 16:28 2979

Mohamed bin Zayed University of Artificial Intelligence and Weizmann Institute of Science establish joint AI Program

INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia

- Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions - QIAGEN's bioinformatic expertise raises predictive biomarker power in INOVIO's patient selection - First-in-class next genera...

2021-02-24 14:45 5798

1 ... 547 548 549550551 552 553 ... 806